Fredun Pharmaceuticals Q2 Results
- BSE: 539730
- NSE: -
- ISIN: INE194R01017
- Sector: Biotechnology & Drugs
BSE
708
34.30 (5.09%)
34.30 (5.09%)Volume7.26 K
Updated: Mon 25 Nov, 2024 | 15:28:54
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹107.35 Cr.(36.22%)
- Operating Profit₹12.89 Cr.(36.65%)
- Profit After Tax₹4.27 Cr.(3.47%)
- Operating Margin12.01%(13.54%)
Note: Comparison is on YoY basis
Quarterly - Fredun Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 107.35 | 61.76 | -% | 81.99 | -% |
| Selling/ General/ Admin Expenses Total | 3.58 | 2.69 | -% | 2.93 | -% |
| Depreciation/ Amortization | 1.06 | 0.92 | -% | 0.94 | -% |
| Other Operating Expenses Total | 9.07 | 4.03 | -% | 3.28 | -% |
| Total Operating Expense | 94.47 | 55.35 | -% | 73.32 | -% |
| Operating Income | 12.89 | 6.41 | -% | 8.67 | -% |
| Net Income Before Taxes | 7.58 | 4.08 | -% | 5.77 | -% |
| Net Income | 4.27 | 2.40 | -% | 3.94 | -% |
| Diluted Normalized EPS | 9.05 | 5.24 | -% | 8.40 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read25 Nov 2024 - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read25 Nov 2024 - Markets
03HUL approves demerger of ice-cream business into separate, listed entity
3 min read25 Nov 2024